Tonsil-derived mesenchymal stem cells enhance allogeneic bone marrow engraftment via collagen IV degradation
Open Access
- 5 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Stem Cell Research & Therapy
- Vol. 12 (1), 1-13
- https://doi.org/10.1186/s13287-021-02414-6
Abstract
Background: Co-transplantation of bone marrow cells (BMCs) and mesenchymal stem cells (MSCs) is used as a strategy to improve the outcomes of bone marrow transplantation. Tonsil-derived MSCs (TMSCs) are a promising source of MSCs for co-transplantation. Previous studies have shown that TMSCs or conditioned media from TMSCs (TMSC-CM) enhance BMC engraftment. However, the factors in TMSCs that promote better engraftment have not yet been identified. Methods: Mice were subjected to a myeloablative regimen of busulfan and cyclophosphamide, and the mRNA expression in the bone marrow was analyzed using an extracellular matrix (ECM) and adhesion molecule-targeted polymerase chain reaction (PCR) array. Nano-liquid chromatography with tandem mass spectrometry, real-time quantitative PCR, western blots, and enzyme-linked immunosorbent assays were used to compare the expression levels of metalloproteinase 3 (MMP3) in MSCs derived from various tissues, including the tonsils, bone marrow, adipose tissue, and umbilical cord. Recipient mice were conditioned with busulfan and cyclophosphamide, and BMCs, either as a sole population or with control or MMP3-knockdown TMSCs, were co-transplanted into these mice. The effects of TMSC-expressed MMP3 were investigated. Additionally, Enzchek collagenase and Transwell migration assays were used to confirm that the collagenase activity of TMSC-expressed MMP3 enhanced BMC migration. Results: Mice subjected to the myeloablative regimen exhibited increased mRNA expression of collagen type IV alpha 1/2 (Col4a1 and Col4a2). Among the various extracellular matrix-modulating proteins secreted by TMSCs, MMP3 was expressed at higher levels in TMSCs than in other MSCs. Mice co-transplanted with BMCs and control TMSCs exhibited a higher survival rate, weight recovery, and bone marrow cellularity compared with mice co-transplanted with BMCs and MMP3-knockdown TMSCs. Control TMSC-CM possessed higher collagenase activity against collagen IV than MMP3-knockdown TMSC-CM. TMSC-CM also accelerated BMC migration by degrading collagen IV in vitro. Conclusions: Collectively, these results indicate that TMSCs enhance BMC engraftment by the secretion of MMP3 for the modulation of the bone marrow extracellular matrix.Keywords
Funding Information
- Korea Health Industry Development Institute (HI18C2392)
This publication has 43 references indexed in Scilit:
- Tonsil-derived stem cells as a new source of adult stem cellsWorld Journal of Stem Cells, 2019
- Application of Tonsil-Derived Mesenchymal Stem Cells in Tissue Regeneration: Concise ReviewThe International Journal of Cell Cloning, 2019
- Late Complications of Allogenic Stem Cells Transplantation in LeukaemiaTissue Engineering and Regenerative Medicine, 2018
- RNA sequencing reveals a transcriptomic portrait of human mesenchymal stem cells from bone marrow, adipose tissue, and palatine tonsilsScientific Reports, 2017
- Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironmentsCancer Immunology, Immunotherapy, 2017
- Tonsil‐derived mesenchymal stem cells (T‐MSCs) prevent Th17‐mediated autoimmune response via regulation of the programmed death‐1/programmed death ligand‐1 (PD‐1/PD‐L1) pathwayJournal of Tissue Engineering and Regenerative Medicine, 2017
- Hematopoietic Stem Cell and Its Bone Marrow NichePublished by Elsevier BV ,2016
- Bioimaging for the monitoring of thein vivodistribution of infused mesenchymal stem cells in a mouse model of the graft-versus-host reactionCell Biology International, 2011
- Cotransplantation of ex vivo–expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantationBlood, 2007
- Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin)Biochemical Journal, 1988